Published online February 16, 2015 DOI: 15,706 View 126 Download 45 Web of Science 46 Crossref Abstract PDFPubReader ePub Type 2 diabetes (T2D) has been known as 'bi-hormonal disorder' since decades ago, the role of glucagon from -cell has languished whereas -cell taking center stage
This serious, chronic, progressive and misunderstood disease requires long-term management to prevent the development of weight-related problems like high blood pressure, high cholesterol, type 2 diabetes, and many others
These findings are in line with the metabolic benefits observed across major semaglutide trials
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
Ver todas las preguntas frecuentes